TY - JOUR
T1 - Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation
AU - Ali, Hashim
AU - Mano, Miguel
AU - Braga, Luca
AU - Naseem, Asma
AU - Marini, Bruna
AU - Vu, Diem My
AU - Collesi, Chiara
AU - Meroni, Germana
AU - Lusic, Marina
AU - Giacca, Mauro
PY - 2019/2/25
Y1 - 2019/2/25
N2 - Productive HIV-1 replication requires viral integrase (IN), which catalyzes integration of the viral genome into the host cell DNA. IN, however, is short lived and is rapidly degraded by the host ubiquitin-proteasome system. To identify the cellular factors responsible for HIV-1 IN degradation, we performed a targeted RNAi screen using a library of siRNAs against all components of the ubiquitin-conjugation machinery using high-content microscopy. Here we report that the E3 RING ligase TRIM33 is a major determinant of HIV-1 IN stability. CD4-positive cells with TRIM33 knock down show increased HIV-1 replication and proviral DNA formation, while those overexpressing the factor display opposite effects. Knock down of TRIM33 reverts the phenotype of an HIV-1 molecular clone carrying substitution of IN serine 57 to alanine, a mutation known to impair viral DNA integration. Thus, TRIM33 acts as a cellular factor restricting HIV-1 infection by preventing provirus formation.
AB - Productive HIV-1 replication requires viral integrase (IN), which catalyzes integration of the viral genome into the host cell DNA. IN, however, is short lived and is rapidly degraded by the host ubiquitin-proteasome system. To identify the cellular factors responsible for HIV-1 IN degradation, we performed a targeted RNAi screen using a library of siRNAs against all components of the ubiquitin-conjugation machinery using high-content microscopy. Here we report that the E3 RING ligase TRIM33 is a major determinant of HIV-1 IN stability. CD4-positive cells with TRIM33 knock down show increased HIV-1 replication and proviral DNA formation, while those overexpressing the factor display opposite effects. Knock down of TRIM33 reverts the phenotype of an HIV-1 molecular clone carrying substitution of IN serine 57 to alanine, a mutation known to impair viral DNA integration. Thus, TRIM33 acts as a cellular factor restricting HIV-1 infection by preventing provirus formation.
UR - http://www.scopus.com/inward/record.url?scp=85062109278&partnerID=8YFLogxK
U2 - 10.1038/s41467-019-08810-0
DO - 10.1038/s41467-019-08810-0
M3 - Article
C2 - 30804369
AN - SCOPUS:85062109278
SN - 2041-1723
VL - 10
SP - 1
EP - 15
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 926
ER -